CS logo
small CS logo
Research Institute of Clinical and Experimental Lymphology

Novosibirsk, Russian Federation

About Research Institute of Clinical and Experimental Lymphology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Research Institute of Clinical and Experimental Lymphology


During the past decade, Research Institute of Clinical and Experimental Lymphology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Research Institute of Clinical and Experimental Lymphology


According to Clinical.Site data, the most researched conditions in "Research Institute of Clinical and Experimental Lymphology" are "Gastroparesis" (2 trials), "Psoriatic Arthritis" (2 trials), "Amyloidosis" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Research Institute of Clinical and Experimental Lymphology" in a lesser frequency.

Clinical Trials Intervention Types at Research Institute of Clinical and Experimental Lymphology


Most popular intervention types in "Research Institute of Clinical and Experimental Lymphology" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Apremilast (CC-10004)" (1 trials) and "Apremilast (CC-10004) Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Research Institute of Clinical and Experimental Lymphology


The vast majority of trials in "Research Institute of Clinical and Experimental Lymphology" are 6 trials for "All" genders.

Clinical Trials Status at Research Institute of Clinical and Experimental Lymphology


Currently, there are NaN active trials in "Research Institute of Clinical and Experimental Lymphology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Research Institute of Clinical and Experimental Lymphology, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Research Institute of Clinical and Experimental Lymphology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status